Literature DB >> 12223411

Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice.

Elizabeth Tonner1, Michael C Barber, Gordon J Allan, James Beattie, John Webster, C Bruce A Whitelaw, David J Flint.   

Abstract

We have previously demonstrated that IGFBP-5 production by mammary epithelial cells increases dramatically during involution of the mammary gland. To demonstrate a causal relationship between IGFBP-5 and cell death we created transgenic mice expressing IGFBP-5 in the mammary gland using a mammary-specific promoter, beta-lactoglobulin. DNA content in the mammary glands of transgenic mice was decreased as early as day 10 of pregnancy. Histological analysis indicated reduced numbers of alveolar end buds, with decreased ductal branching. Transgenic dams produced IGFBP-5 in their milk at concentrations similar to those achieved at the end of normal lactation. Mammary cell number and milk synthesis were both decreased by approximately 50% during the first 10 days of lactation. BrdU labelling was decreased, whereas DNA ladders were increased in transgenic animals on day 1 of lactation. On day 2 postpartum, the epithelial invasion of the mammary fat pad was clearly impaired in transgenic animals. The concentrations of the pro-apoptotic molecule caspase-3 and of plasmin were both increased in transgenic animals whilst the concentrations of 2 prosurvival molecules Bcl-2 and Bcl-x(L)were both decreased. In order to examine whether IGFBP-5 acts by inhibiting the survival effect of IGF-I we examined IGF receptor phosphorylation and Akt phosphorylation and showed that both were inhibited. We attempted to "rescue" the transgenic phenotype by using growth hormone to increase endogenous IGF-I concentrations or by implanting minipumps delivering an IGF-1 analogue, R(3)-IGF-1, which binds weakly to IGFBP-5. Growth hormone treatment failed to affect mammary development suggesting that increased concentrations of endogenous IGF-1 are insufficient to overcome the high concentrations of IGFBP-5 produced by these transgenic animals. In contrast mammary development (gland weight and DNA content) was normalised by R3-IGF-I although milk production was only partially restored. This is the first demonstration that over-expression of IGFBP-5 can lead to; impaired mammary development, increased expression of the pro-apoptotic molecule caspase-3, increased plasmin generation and decreased expression of pro-survival molecules of the Bcl-2 family. It clearly demonstrates that IGF-I is an important developmental/survival factor for the mammary gland and, furthermore, this cell death programme may be utilised in a wide variety of tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223411     DOI: 10.1242/dev.129.19.4547

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  33 in total

Review 1.  Apoptosis regulation in the mammary gland.

Authors:  K A Green; C H Streuli
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

2.  Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution.

Authors:  Michael C Rudolph; James L McManaman; Larry Hunter; Tzulip Phang; Margaret C Neville
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

Review 3.  The molecular culprits underlying precocious mammary gland involution.

Authors:  Kate D Sutherland; Geoffrey J Lindeman; Jane E Visvader
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

Review 4.  Mammary gland involution as a multi-step process.

Authors:  Torsten Stein; Nathan Salomonis; Barry A Gusterson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

Review 5.  Role of insulin-like growth factor binding proteins in mammary gland development.

Authors:  D J Flint; E Tonner; J Beattie; G J Allan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-08       Impact factor: 2.673

6.  IGFBP-2 and -5: important regulators of normal and neoplastic mammary gland physiology.

Authors:  James Beattie; Yousef Hawsawi; Hanaa Alkharobi; Reem El-Gendy
Journal:  J Cell Commun Signal       Date:  2015-02-03       Impact factor: 5.782

7.  An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.

Authors:  Asaf Wyszynski; Chi-Chen Hong; Kristin Lam; Kyriaki Michailidou; Christian Lytle; Song Yao; Yali Zhang; Manjeet K Bolla; Qin Wang; Joe Dennis; John L Hopper; Melissa C Southey; Marjanka K Schmidt; Annegien Broeks; Kenneth Muir; Artitaya Lophatananon; Peter A Fasching; Matthias W Beckmann; Julian Peto; Isabel Dos-Santos-Silva; Elinor J Sawyer; Ian Tomlinson; Barbara Burwinkel; Frederik Marme; Pascal Guénel; Thérèse Truong; Stig E Bojesen; Børge G Nordestgaard; Anna González-Neira; Javier Benitez; Susan L Neuhausen; Hermann Brenner; Aida Karina Dieffenbach; Alfons Meindl; Rita K Schmutzler; Hiltrud Brauch; Heli Nevanlinna; Sofia Khan; Keitaro Matsuo; Hidemi Ito; Thilo Dörk; Natalia V Bogdanova; Annika Lindblom; Sara Margolin; Arto Mannermaa; Veli-Matti Kosma; Anna H Wu; David Van Den Berg; Diether Lambrechts; Hans Wildiers; Jenny Chang-Claude; Anja Rudolph; Paolo Radice; Paolo Peterlongo; Fergus J Couch; Janet E Olson; Graham G Giles; Roger L Milne; Christopher A Haiman; Brian E Henderson; Martine Dumont; Soo Hwang Teo; Tien Y Wong; Vessela Kristensen; Wei Zheng; Jirong Long; Robert Winqvist; Katri Pylkäs; Irene L Andrulis; Julia A Knight; Peter Devilee; Caroline Seynaeve; Montserrat García-Closas; Jonine Figueroa; Daniel Klevebring; Kamila Czene; Maartje J Hooning; Ans M W van den Ouweland; Hatef Darabi; Xiao-Ou Shu; Yu-Tang Gao; Angela Cox; William Blot; Lisa B Signorello; Mitul Shah; Daehee Kang; Ji-Yeob Choi; Mikael Hartman; Hui Miao; Ute Hamann; Anna Jakubowska; Jan Lubinski; Suleeporn Sangrajrang; James McKay; Amanda E Toland; Drakoulis Yannoukakos; Chen-Yang Shen; Pei-Ei Wu; Anthony Swerdlow; Nick Orr; Jacques Simard; Paul D P Pharoah; Alison M Dunning; Georgia Chenevix-Trench; Per Hall; Elisa Bandera; Chris Amos; Christine Ambrosone; Douglas F Easton; Michael D Cole
Journal:  Hum Mol Genet       Date:  2016-07-11       Impact factor: 6.150

Review 8.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

Review 9.  Integrative eQTL-based analyses reveal the biology of breast cancer risk loci.

Authors:  Qiyuan Li; Ji-Heui Seo; Barbara Stranger; Aaron McKenna; Itsik Pe'er; Thomas Laframboise; Myles Brown; Svitlana Tyekucheva; Matthew L Freedman
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

Review 10.  A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.

Authors:  Torsten Stein; Nathan Salomonis; Dimitry S A Nuyten; Marc J van de Vijver; Barry A Gusterson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-30       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.